Primary Record
Masitinib
- In stock
- 8,441 g
- Purity
- 98.8 %
- CAS
- 790299-79-5
Compound Identifiers & Properties
- CAS
- 790299-79-5
- PubChem CID
- 10074640
- SMILES
- CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC(=CS4)C5=CN=CC=C5
- Canonical SMILES
- Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nc(-c2cccnc2)cs1
Names & Synonyms
- Masitinib
- Masatinib
- 790299-79-5
- Masivet
- Masitinib (AB1010)
- Mastinib
- Kinavet
- masitinibum
- Masitinib [INN]
- Masitinib?
- AB1010
- Kinavet CA-1
- Masitinib (INN)
- Masitinib (Standard)
- Masitinib/AB1010
- AB-1010
- MASITINIB [MI]
- MFCD09954132
- RefChem:925347
- M59NC4E26P
- UNII-M59NC4E26P
- AB 1010
- D0MW0N
- MASITINIB [MART.]
- AB1010,Masivet,Masitinib
- MASITINIB [WHO-DD]
- C28H30N6OS
- CHEMBL1908391
- cc-179
- CHEBI:63450
- MLS006010167
- Masican (proposed trade name)
- SCHEMBL717239
- GTPL5656
- orb1305268
- SCHEMBL29353195
- SCHEMBL29355443
- CTK8E8465
- EX-A080
- L01XE22
- SYN1053
- WJEOLQLKVOPQFV-UHFFFAOYSA-N
- BDBM734447
- DTXSID001000207
- GLXC-90398
- HMS3244J04
- HMS3244J08
- HMS3244J12
- HMS3295G03
- HMS3654I13
- HMS3884E03
- HMS5079A09
- AMY14908
- BCP01820
- ABP000249
- BDBM50355495
- EBC-11386
- HY-10209R
- NSC755400
- NSC800789
- RS0047
- s1064
- ZINC34177219
- AKOS005146325
- AC-1908
- AN-5305
- BCP9000897
- CCG-269680
- CS-0134
- DB11526
- FM65073
- GS-6164
- NSC-755400
- NSC-800789
- SB14844
- SDCCGSBI-0654333.P001
- CID10074640
- KS-000001C9
- NCGC00241103-01
- NCGC00241103-03
- NCGC00241103-04
- NCGC00241103-06
- NCGC00241103-09
- US20250129067, Compound Masitinib
- 4CA-0798
- AC-30632
- AJ-87321
- BC686818
- CID 10074640
- HY-10209
- SC-23334
- SMR004701275
- SY259010
- 4-[(4-Methyl-1-piperazinyl)methyl]-N-[4-methyl-3-[[4-(3-pyridinyl)-2-thiazolyl]amino]phenyl]benzamide
- AB0008058
- N-(4-Methyl-3-((4-(pyridin-3-yl)thiazol-2-yl)amino)phenyl)-4-((4-methylpiperazin-1-yl)methyl)benzamide
- RT-013665
- A2942
- FT-0652399
- NS00072058
- SW219247-1
- EC-000.2316
- J2.920.360A
- N-(4-methyl-3-{[4-(pyridin-3-yl)-1,3-thiazol-2-yl]amino}phenyl)-4-[(4-methylpiperazin-1-yl)methyl]benzamide
- A10558
- D10229
- W-5430
- AB01274735-01
- AB01274735_02
- 299M795
- A839556
- I14-1978
- N-(4-methyl-3-(4-(pyridin-3-yl)thiazol-2-ylamino)phenyl)-4-((4-methylpiperazin-1-yl)methyl)benzamide
- Q1907109
- BRD-K71035033-001-01-4
- BRD-K71035033-001-07-1
- BRD-K71035033-001-08-9
- 4-[(4-methylpiperazin-1-yl)methyl]-N-(4-methyl-3-{[4-(pyridin-3-yl)-1,3-thiazol-2-yl]amino}phenyl)benzamide
- B0084-077384
- 4-((4-Methylpiperazin-1-yl)methyl)-N-(4-methyl-3-((4-(pyridin-3-yl)-1,3-thiazol-2-yl)amino)phenyl)benzamide
- 4-[(4-methylpiperazin-1-yl)methyl]-N-[4-methyl-3-[[4-(3-pyridyl)thiazol-2-yl]amino]phenyl]benzamide
- 4-((4-METHYLPIPERAZIN-1-YL)METHYL)-N-(4-METHYL-3-((4-PYRIDIN-3-YL-1,3-THIAZOL-2-YL)AMINO)PHENYL)BENZAMIDE
- 4-[(4-methylpiperazin-1-yl)methyl]-N-[4-methyl-3-[(4-pyridin-3-yl-1,3-thiazol-2-yl)amino]phenyl]benzamide
- 4-(4-Methyl-piperazin-1-ylmethyl)-N-[4-methyl-3-(4-pyridin-3-yl-thiazol-2-ylamino) -phenyl]-benzamide
- 4-(4-Methyl-piperazin-1-ylmethyl)-N-[4-methyl-3-(4-pyridin-3-yl-thiazol-2-ylamino)-phenyl]-benzamide
- 4-[(4-Methylpiperazin-1-yl)methyl]-N-(4-methyl-3-{[4-(pyridin-3-yl)-1,3-thiazol-2(3H)-ylidene]amino}phenyl)benzamide
- Benzamide, 4-[(4-methyl-1-piperazinyl)methyl]-N-[4-methyl-3-[[4-(3-pyridinyl)-2-thiazolyl]amino]phenyl]-; 4-[(4-Methyl-1-piperazinyl)methyl]-N-[4-methyl-3-[[4-(3-pyridinyl)-2-thiazolyl]amino]phenyl]benzamide; Masitinib; Masivet
- G65
- N-(4-methyl-3-((4-(pyridin-3-yl)-1,3-thiazol-2-yl)amino)phenyl)-4-((4-methylpiperazin-1-yl)methyl)benzamide
- N-[4-Methyl-3-[[4-(3-Pyridyl)-2-thiazolyl]amino]phenyl]-4-[(4-methyl-1-piperazinyl)methyl]benzamide
- N-[4-Methyl-3-[4-(3-pyridyl)-2-thiazolylamino]phenyl]-4-(4-methylpiperazinomethyl)benzamide